LuinaBio

LuinaBio is a premier Australian contract development and manufacturing organization (CDMO) that specializes in microbial-based products, including recombinant proteins, vaccines, and live biotherapeutic products (LBPs). Operating out of Brisbane, the company offers a full suite of services from early-stage process development to cGMP-compliant manufacturing for clinical and commercial use. LuinaBio is a global leader in the microbiome space, providing specialized anaerobic fermentation capabilities required for complex live biotherapeutics. In September 2021, the company was acquired by Eurofins Scientific, becoming part of the Eurofins BioPharma Product Testing network to expand its global reach and service offerings. The facility is licensed by the Therapeutic Goods Administration (TGA) and provides essential infrastructure for biotech companies looking to scale their microbial production.